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AbstrAct:
Tetraploidization is believed to promote genome instability and tumorigenesis. 
Whether tetraploids per se are intrinsically unstable and transforming remain 
incompletely understood. In this report, tetraploidization was induced with cell 
fusion using mouse fibroblasts. Due to the unequal segregation of chromosomes 
during multipolar mitosis, the majority of cells were eliminated by p53-dependent 
mechanisms after tetraploidization. The rare tetraploid fibroblasts that were able to 
undergo bipolar mitosis remained chromosomally stable and nontransformed over 
many generations. Suppression of p53 functions during tetraploidization, either by 
RNA interference or by using p53-deficient mouse fibroblasts, produced cells that 
were chromosomally unstable. They were fast growing and displayed anchorage-
independent growth in soft agar. In contrast, impairment of p53 functions after 
tetraploids were established was ineffective in triggering chromosomal instability 
and transformation. Collectively, these results are consistent with a model that 
during early stages of tetraploidization, the lack of p53 promotes the survival of 
chromosomally unstable sub-tetraploids, leading to transformation. Once tetraploids 
are established, however, p53 is not essential for maintaining chromosome stability. 
INtrODUctION
Limiting genome replication to once per cell cycle 
is critical for maintaining genome stability. A growing 
body of evidence indicates that polyploidization can 
initiate chromosomal instability and transformation [1]. 
While rereplication is stringently prevented in the normal 
cell cycle, multiple rounds of genome reduplication, 
called endoreduplication, occur in cell types such as 
megakaryocytes, trophoblasts, and plant cells [2]. 
Polyploidization is also believed to be an essential step 
during evolution. In his seminal work, Ohno proposed that 
whole genome duplication provides the primary source of 
redundant genes for new evolutionary opportunities [3]. 
Likewise, the multistep progression of cancer – including 
initiation, progression, heterogeneity, and drug resistance 
– is a product of evolutionary processes [4]. The extra 
sets of chromosomes after polyploidization may act as a 
reservoir of genetic materials to allow clonal evolution 
of tumor.
The majority of cancer cells are highly aneuploid, 
displaying dynamic karyotypic changes including gain 
or loss of whole chromosomes. Tetraploid cells are 
commonly found in early stages of tumors. Notable 
examples include Barrett’s esophagus [5,6] and cervical 
carcinoma [7]. Several studies with yeast [8,9] and 
mammalian cells [10,11] have provided evidence that 
tetraploidization increases chromosome instability. 
Moreover, tetraploidy may be an intermediate state in 
transformation. For example, it was found that during 
transformation of epithelial cells from mouse salivary 
glands, tetraploid cells appeared before they undergo a 
period of chromosome instability and loss [11]. Many 
viruses can induce tetraploidy via cell fusions. Evidence 
from  in vitro and animal models also suggest a link 
between cell fusion induced by viruses (which then 
caused tetraploidy) and cancer [12].
A seminal study by Fujiwara et al. (2005) indicates 
that tetraploids can be generated by transiently blocking 
cytokinesis in p53-null mouse mammary epithelial cells. 
Importantly, tetraploidization promotes aneuploidy 
and tumorigenesis [10]. The presence of p53 normally Oncotarget 2010; 1:  583 - 595 584 www.impactjournals.com/oncotarget
Figure 1: tetraploidization and p53 depletion induce chromosome instability and transformation.
(A) Dcb-induced tetraploidization. Swiss 3T3 fibroblasts were treated with DCB and harvested at the indicated time points for flow 
cytometry analysis. The positions of 2N, 4N, and 8N DNA contents are indicated.
(b) Dcb-induced tetraploids are chromosomally unstable. Fibroblasts were either mock-treated or incubated with DCB for 24 h. 
The DCB-treated cells were then harvested at the three subsequent passages (P1, P2, and P3) for flow cytometry analysis. The positions of 2N, 
4N, and 8N DNA contents are indicated. 
(c) Activation of p53 after Dcb-induced tetraploidization. Fibroblasts were transfected with control or p53 siRNA. The cells were 
then treated with DCB for 24 h. After washing out the DCB, the cells were propagated in drug-free medium and harvested at three subsequent 
passages (P1, P2, and P3). Lysates were prepared and analyzed with immunoblotting. 
(D) transformation is induced by Dcb in combination with p53 downregulation. Fibroblasts were transfected with either control 
or p53 siRNA. At 24 h after transfection, the cells were treated with either buffer or DCB for 24 h. The cells were allowed to recover for three 
passages and subjected to soft agar transformation assay. 
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suppresses the generation of tetraploid cells, presumably 
by activating the intrinsic apoptotic pathway [13]. 
Several processes that cause tetraploidization, including 
chromosome nondisjunction (which promotes cleavage 
furrow regression) [14], persistent telomere damage 
[15], and virus infection-mediated cell fusion (called 
heterokaryon) [16] are believed to be important to 
tumorigenesis. These and other studies provide strong 
evidence of the importance of tetraploidization as an early 
step in tumorigenesis.
A p53-dependent “tetraploidy checkpoint” has 
been proposed to prevent S phase entry in cells that 
have undergone mitotic slippage or aborted cytokinesis 
[17]. The checkpoint is believed to sense the increase 
in chromosome number and halt the cell in a tetraploid 
G1 state. However, the existence of this checkpoint 
has been disputed [10,18,19]. It is likely that the p53-
dependent arrest after tetraploidization is mainly due to 
DNA damage or centrosomal stress during the aberrant 
mitosis [2]. Indeed, γ-H2AX can readily be detected in 
cells undergoing prolonged mitotic arrest [20,21]; even 
though it is questionable whether the γ-H2AX induced 
during mitosis is necessary an indicator of DNA damage 
[22]. Another possibility that has been proposed is that the 
lack of transcription during mitotic arrest induces stress 
and triggers the subsequent cell cycle arrest [23]. 
How tetraploidization promotes chromosome 
instability remains incompletely understood. At least in 
yeast, the increase in improper microtubule-kinetochore 
attachments in tetraploids contributes to chromosome 
instability [9]. The extra centrosomes after tetraploidization 
are also critical determinants of chromosome instability 
[24]. In fact, an increase centrosome number is a 
common characteristic of several tumors [25]. Because 
centrosomes are microtubule organization centers, cells 
with supernumerary centrosomes form multipolar mitotic 
spindles and display other errors during chromosomal 
segregation. The uneven segregation of genetic materials 
into daughter cells results in different fates, including 
mitotic catastrophe, aneuploidy, and transformation. 
Nevertheless, multipolar mitosis can be suppressed in the 
cell either by functional silencing of extra centrosomes or 
by centrosome clustering [26-28]. 
Although tetraploidization can promote chromosome 
instability, there is evidence that suggests tetraploidy is a 
relatively more stable state than other aneuploidy [2]. Our 
group also found that cells generated from tetraploidization 
of Hep3B cells are relatively stable [29]. However, 
cancer cell lines such as Hep3B do not contain functional 
p53 and are already aneuploid and transformed before 
tetraploidization. In this study, we examined whether 
the tetraploidy state is intrinsically unstable by using 
untransformed mouse fibroblasts. We found that tetraploid 
fibroblasts generated by cell fusion are chromosomally 
stable over many generations, even when p53 is depleted. 
In contrast, tetraploids induced in the absence of p53 are 
chromosomally unstable and transformed. 
rEsULts
tetraploidization is accompanied with a rapid 
loss of chromosomal stability
Swiss 3T3 fibroblasts expressing wild type p53 were 
used to examine genome instability after tetraploidization. 
Swiss 3T3 were used instead of primary fibroblasts because 
p53 is frequently mutated when MEFs are immortalized 
using the 3T3 protocol. To induce tetraploidization, 
the cells were incubated with dihydrocytochalasin B 
(DCB),  a  drug  that  interferes  with  actin  assembly,  to 
inhibit  cytokinesis.  Flow  cytometry  analysis  confirmed 
that DCB-treated cells displayed mainly tetraploid DNA 
contents  relative  to  untreated  cells  (Figure  1A).  Cells 
containing up to 8N DNA contents could be detected at 24 
h after DCB treatment. 
After treatment with DCB for 24 h, the fibroblasts 
were propagated in drug-free medium. Although 
tetraploids could be detected at passage 1, they were 
progressively depleted during subsequent passages (Figure 
1B). Immunoblotting of the lysates revealed that p53 was 
strongly activated after tetraploidization (Figure 1C, lanes 
2 and 6). These results suggest that tetraploidization of 
fibroblasts  was  associated  with  an  activation  of  p53 
followed by the disappearance of the tetraploids. 
To  determine  if  DCB-induced  tetraploidization 
could promote transformation, cells were plated in soft 
agar to assay for anchorage-independent growth. Figure 
1D  shows  that  DCB-treated  3T3  cells  were  unable  to 
form colonies in soft agar. By contrast, depletion of p53 
with three siRNAs (see later for the characterization of 
the siRNAs) in DCB-treated 3T3 stimulated anchorage-
independent growth. As a control, transfection of p53 
siRNA in control 3T3 cells did not promote anchorage-
independent  growth.  Immunoblotting  verified  that  the 
induction of p53 after DCB treatment was suppressed by 
the siRNAs (Figure 1C). These data are in agreement with 
the findings of Fujiwara et al. (2005) that primary cells 
can be transformed by a combination of tetraploidization 
and a loss of p53. 
Collectively,  these  observations  suggest  that 
tetraploidy induced in 3T3 fibroblasts by DCB treatment 
was unstable, and that transformation could be promoted 
by the downregulation of p53. 
Generation of tetraploid 3T3 fibroblasts by cell 
fusion
To examine the contribution of p53 to genome 
stability after tetraploidization, p53-/- mouse embryonic 
fibroblasts were propagated using a 3T3 protocol (called Oncotarget 2010; 1:  583 - 595 586 www.impactjournals.com/oncotarget
p53-/-3T3 herein). Given that most DCB-treated cells loss 
tetraploidy during passage, more stable tetraploid cells 
were generated with a strategy involving cell fusion and 
antibiotic selection (Figure 2A). Plasmids expressing 
blasticidin- or G418-resistant gene were first transfected 
individually into 3T3 or p53-/-3T3. Stable cell lines 
resistant to the respective antibiotics were generated after 
selection. Cell-cell fusion was then performed between 
serum-starved blasticidin- and G418-resistant cells. 
Figure 2A verifies that immediately after fusion, some 
cells contained two nuclei and four centrosomes. The 
cells were then selected with both blasticidin and G418. 
More than a dozen of individual colonies from both p53-
positive  and  -negative  background  were  isolated.  Data 
from several representative clones are presented in this 
paper. 
Examination of the cell lines obtained by fusion 
with  indirect  fluorescent  microscopy  revealed  that  the 
majority of cells underwent biopolar mitosis (~98%). Four 
centrosomes were frequently observed in interphase cells 
and also occasionally in prometaphase cells (Figure 2B). 
However, only rarely were we able to find cells with more 
than two microtubule organization centers at later stages 
of mitosis (~2% of mitotic cells). These data suggest 
that despite the presence of multiple centrosomes during 
interphase, the cells were able to undergo bipolar mitosis, 
possibly due to mechanisms involving centrosome 
clustering [25]. 
We next examined the DNA contents of the cells 
obtained by cell fusion. The 3T3-fusion clones contained 
approximate double the amount of DNA as the parental 
cells (e.g. clone #2 and #27) (Figure 3A). In marked 
contrast, most p53-/-3T3-fusion clones contained sub-
tetraploidy amount of DNA (e.g. clone #5). Some clones 
did contain more DNA than the parental cells, but they 
were clearly less than tetraploidy (e.g. clone #10). In 
agreement with the flow cytometry results, direct counting 
of chromosomes after mitotic spread indicated that 3T3-
fusion cells were roughly tetraploids (Figure 3B). 
These results indicate that while fusion of wild type 
3T3 fibroblasts generated stable tetraploids, fusion of cells 
without p53 favored the appearance of sub-tetraploids. 
These results are consistent with the idea that cells with 
chromosomal instability following tetraploidization could 
Figure 2: Generation of tetraploids by cell fusion.
(A) Fusion of fibroblasts. Fusion of 3T3 or p53-/- 3T3 fibroblasts was as described in Materials and Methods. Schematic diagram of the cell 
fusion and selection procedure is shown. At 6 h after fusion, the cells were fixed and centrosomes were visualized with immunostaining for 
γ-tubulin (arrows). The nuclei were stained with DAPI. 
(B) Immunofluorescence microscopy of a representative cell line obtained from fusion of 3T3 cells (clone #2). Centrosomes 
were visualized by γ-tubulin staining (arrows). DNA was stained with DAPI. Representative examples of cells from different phases of the 
cell cycle are shown. While interphase cells containing four centrosomes were frequently observed, prometaphase cells containing multiple 
centrosomes were observed with low frequency. 
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Figure 3: tetraploidy stability is p53-dependent.
(A) tetraploidy DNA contents can be maintained after cell fusion in p53-containing cells. Stable cell lines resistant to G418 or 
blasticidin were generated from 3T3 or p53-/-3T3. These cells were fused to generate fusion cell lines. Flow cytometry analysis of the parental 
cell lines and representative clones of fused cells are shown. The positions of the 2N and 4N DNA contents in relation to the parental cell lines 
are indicated. 
(B) 3T3-fusion cells contain roughly double the chromosome number as the parental 3T3 fibroblasts. Asynchronously growing 
3T3, 3T3-fusion, p53-/-3T3 and p53-/-3T3-fusion were fixed and processed for chromosome spread. The number of chromosomes was analyzed. 
A B
0
1
2
3
4
5
0
4
8
1
2
1
6
2
0
2
4
2
8
3
2
3
6
4
0
4
4
4
8
5
2
5
6
6
0
6
4
6
8
7
2
7
6
8
0
8
4
8
8
9
2
9
6
1
0
0
1
0
4
1
0
8
1
1
2
1
1
6
1
2
0
1
2
4
1
2
8
1
3
2
1
3
6
1
4
0
0
1
2
3
4
0
4
8
1
2
1
6
2
0
2
4
2
8
3
2
3
6
4
0
4
4
4
8
5
2
5
6
6
0
6
4
6
8
7
2
7
6
8
0
8
4
8
8
9
2
9
6
1
0
0
1
0
4
1
0
8
1
1
2
1
1
6
1
2
0
1
2
4
1
2
8
1
3
2
1
3
6
1
4
0
0
1
2
3
4
5
0
4
8
1
2
1
6
2
0
2
4
2
8
3
2
3
6
4
0
4
4
4
8
5
2
5
6
6
0
6
4
6
8
7
2
7
6
8
0
8
4
8
8
9
2
9
6
1
0
0
1
0
4
1
0
8
1
1
2
1
1
6
1
2
0
1
2
4
1
2
8
1
3
2
1
3
6
1
4
0
0
1
2
3
4
0
4
8
1
2
1
6
2
0
2
4
2
8
3
2
3
6
4
0
4
4
4
8
5
2
5
6
6
0
6
4
6
8
7
2
7
6
8
0
8
4
8
8
9
2
9
6
1
0
0
1
0
4
1
0
8
1
1
2
1
1
6
1
2
0
1
2
4
1
2
8
1
3
2
1
3
6
1
4
0
Number of chromosomes
N
u
m
b
e
r
 
o
f
 
c
e
l
l
s
N
u
m
b
e
r
 
o
f
 
c
e
l
l
s
N
u
m
b
e
r
 
o
f
 
c
e
l
l
s
N
u
m
b
e
r
 
o
f
 
c
e
l
l
s 3T3
p53   
-/-
p53   -fusion
(clone 10)
-/-
3T3-fusion
(clone 20)
2N 4N
p53   
-/-(G418)
p53   
-/-
p53   
-/-(Bsd)
p53   -fusion
(clone 10)
-/-
3T3
3T3
(G418)
3T3
(Bsd)
3T3-fusion
(clone 2)
2N 4N
3T3-fusion
(clone 27)
p53   -fusion
(clone 5)
-/-
Figure 3Oncotarget 2010; 1:  583 - 595 588 www.impactjournals.com/oncotarget
be eliminated by p53-dependent pathways.
p53-containing tetraploids are chromosomally 
stable even after extensive culturing
To see if proliferation is affected by tetraploidization, 
3T3 and 3T3-fusion were pulse-labeled with BrdU and 
analyzed by bivariate flow cytometry. Figure 4A shows 
that the 3T3-fusion cells displayed similar cell cycle 
distribution as the parental 3T3 cells during the unperturbed 
cell cycle. To examine mitosis in more detail, cells were 
transfected with plasmids expressing GFP-tagged histone 
H2B and tracked with time-lapse microscopy. Figure 4B 
shows that the duration of mitosis was marginally extended 
in 3T3-fusion. Finally, the growth rates of 3T3 and 3T3-
fusion were also comparable (Figure 4C). In contrast, p53-
/-3T3-fusion cells proliferated significantly faster than the 
parental p53-/-3T3 (Figure 4C). These results indicate that 
cells generated by fusion in the absence of p53 displayed 
proliferation advantage over the diploid counterparts.
To examine if transformation is promoted by 
tetraploidization, anchorage-independent growth assays 
Figure 4: Tetraploidization of p53-containing fibroblasts exerts negligible effects on cell cycle progression. 
(A) cell cycle distribution of 3t3 cells is not affected by tetraploidization. 3T3 or 3T3-fusion cells were pulsed labeled with BrdU. 
The cells were then processed for BrdU staining and flow cytometry analysis. The percentage of cells in different phases of the cell cycle is 
displayed. 
(b) tetraploidization increases the mitotic length. Cells from 3T3-fusion (clone #2) and the parental 3T3 fibroblasts were transfected 
with a histone H2B-GFP construct. Individual cells were tracked with time-lapse microscopy. The length of mitosis (from DNA condensation 
to anaphase) of individual cells was measured (n=35). 
(c) the growth rate of p53-/-3T3 but not 3T3 fibroblasts is significantly enhanced after fusion. Time-dependent population 
doubling was measured for the indicated cell lines. 
0
2
4
6
8
10
12
14
024681 01 2
p53   -fusion
(clone 10)
-/-
3T3-fusion
(clone 2)
p53   
-/-
3T3
P
o
p
u
l
a
t
i
o
n
 
d
o
u
b
l
i
n
g
Time (days)
A
3T3 3T3-fusion
(clone 2)
16% 40% 46% 14%
44% 40%
B
C
Length of mitosis (min)
N
u
m
b
e
r
 
o
f
 
c
e
l
l
s
0
2
4
6
8
10
12
14
16
<20
20-25
25-30
30-35
35-40
40-45
45-50
50-55
3T3
3T3-fusion
Figure 4Oncotarget 2010; 1:  583 - 595 589 www.impactjournals.com/oncotarget
were performed for the various fusion clones. Similar to the 
parental 3T3 fibroblasts, 3T3-fusion clones were unable to 
form colonies in soft agar (Figure 5A). In contrast, p53-/-
3T3-fusion clones could readily proliferate. In agreement 
with the soft agar assays, cells from p53-/-3T3-fusion, but 
not 3T3-fusion, were able to form tumors after injection 
into nude mice (data not shown). These data indicate 
that while cell fusion in the absence of p53 promoted 
transformation, stable tetraploids generated by fusion of 
p53-positive fibroblasts remained non-transformed. 
Given that 3T3-fusion cells were tetraploids and non-
transformed, we next examined whether the tetraploidy 
state remained stable during long-term culturing. 3T3-
fusion cells were carefully cultured with 3T3 protocol 
for over 100 days (up to passage 34). Figure 5B shows 
that the tetraploid DNA content was maintained over the 
time. Similar growth rate was also preserved during the 
extensive  culturing  (Figure  5C).  Moreover,  3T3-fusion 
cells from both early and late passages (>30) were unable 
to grow in soft agar or to induce tumor in nude mice. 
Figure 5: tetraploids containing p53 are chromosomally stable and not transformed after extensive culturing. 
(A) cell fusion induces transformation in cells with p53-negative but not wild type background. Transformation of the 
indicated cell lines was assessed by soft agar assays. 
(b) tetraploidy in 3t3 fusion cell lines is maintained after long-term culturing. The DNA contents of Swiss 3T3 and 3T3 fusion 
cells collected at different passages were analyzed with flow cytometry. The positions of the 2N and 4N DNA contents in relation to the parental 
cell lines are indicated. 
(c) the growth rate of 3t3 fusion cells does not alter during long-term culturing. The growth curves of selected clones of p53-
/-3T3 fusion and 3T3 fusion are shown. 
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Collectively,  these  data  indicate  that  unlike  cells  from 
p53-/- background, tetraploids generated from 3T3 were 
chromosomally stable and remain untransformed over 
many generations. 
Downregulation of p53 in established tetraploids 
does not trigger chromosome instability or 
transformation 
Given that the absence of p53 during tetraploidization 
promoted chromosomal instability and transformation, 
we next examined if downregulation of p53 after 
tetraploidization could also induce similar effects. To 
this end, we first validated that both 3T3 and 3T3-fusion 
indeed contained functional p53. Figure 6A shows that 
p53 and its downstream target p21CIP1/WAF1 were induced 
after treatment with the genotoxic agents Adriamycin and 
nocodazole. The p53 pathway was also induced to a lesser 
extent by hydroxyurea and ionizing radiation. These data 
confirm that 3T3-fusion still retained functional p53. 
To downregulate p53, three siRNAs were transfected 
either individually or in a mixture. Figure 6B shows that 
the Adriamycin-induced p53 and p21CIP1/WAF1 in 3T3 
fibroblasts could be suppressed by the siRNAs (lanes 4, 
6, 8, and 10). As a negative control, depletion of cyclin 
Figure 6: Tetraploid fibroblasts retain functional p53 pathways.
(A) the p53 pathway is activated in both 3t3 and tetraploid 3t3 by various stresses. 3T3 and 3T3-fusion cells were treated 
with Adriamycin (ADR), hydroxyurea (HU), nocodazole (NOC), or ionizing radiation (IR). After 16 h, the cells were harvested and cell-free 
extracts were prepared. The expression of p53 and p21CIP1/WAF1 was detected with immunoblotting. Equal loading of lysates was confirmed with 
immunoblotting for actin. 
(b) suppression of Adriamycin-induced p53-p21CIP1/WAF1 responses in 3T3 fibroblasts. Cells were transfected with control, 
individual p53 siRNA, a mixture of three p53 siRNAs, or cyclin B1 siRNA. At 24 h after transfection, the cells were either mock-treated or 
incubated with Adriamycin. After 16 h, the cells were harvested and analyzed with immunoblotting. 
(c) suppression of Adriamycin-induced p53-p21CIP1/WAF1 responses in 3t3-fusion cells. 3T3 or 3T3-fusion cells were transfected 
with either control or p53 siRNAs (mixture). At 24 h after transfection, the cells were either mock-treated or incubated with Adriamycin. After 
16 h, the cells were harvested and analyzed with immunoblotting. Actin analysis was included to assess protein loading and transfer.
(D) Depletion of p53 disrupts the G1 DNA damage checkpoint in both 3t3 and tetraploid 3t3-fusion. 3T3 or 3T3-fusion cells 
were transfected and treated as in panel (C). The cells were then fixed and analyzed with flow cytometry. The positions of the 2N and 4N DNA 
contents in relation to the 3T3 fibroblasts are indicated. 
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B1 did not affect the activation of p53-p21CIP1/WAF1 by 
Adriamycin (lane 12). Likewise, activation of the p53-
p21CIP1/WAF1 pathway by Adriamycin in 3T3-fusion could 
be suppressed by the p53 siRNAs (Figure 6C). 
To  confirm  that  the  DNA  damage  responses  in 
3T3  and  tetraploid  fibroblasts  were  impaired  after  p53 
depletion, the cells were analyzed with flow cytometry 
(Figure 6D). While the G1 DNA damage checkpoint is 
mediated by the p53-p21CIP1/WAF1 axis, the intra-S and 
G2 DNA damage checkpoints mainly rely on the ATM/
ATR-CHK1/CHK2 axis that is independent on p53 [30]. 
Flow cytometry analysis revealed the presence of cells 
in G1, late S phase, and G2 phase following Adriamycin 
treatment (Figure 6D), indicating the functioning of the 
checkpoints in both 3T3 and 3T3-fusion fibroblasts. After 
depletion of p53 with siRNAs, the Adriamycin-mediated 
G1 delay was abolished in both cell lines. In contrast, 
the p53-independent intra-S or G2 checkpoints were 
not affected. Taken together, these data indicate that the 
genotoxic stress-induced p53 responses are functional in 
both 3T3 and 3T3-fusion, and that they can be effectively 
disrupted by siRNAs. 
We then analyzed if downregulation of p53 in 3T3-
fusion cells could destabilize the tetraploidy state and lead 
to transformation. Three rounds of siRNA transfection 
were performed to ensure that p53 was depleted over 
several generations. Figure 7A shows that the p53 siRNA 
treatment did not lead to a collapse of the tetraploidy 
state. Furthermore, the cells did not acquire transformed 
phenotype in soft agar (Figure 7B) or nude mice 
tumorigenicity assays (data not shown). The same results 
were obtained with cells from early or late passages of two 
independent 3T3-fusion clones. As a positive control, cells 
generated from fusion of p53-/-3T3 displayed anchorage-
independent  growth  (Figure  7B).  Collectively,  these 
results suggest that once tetraploid fibroblasts are stably 
established, chromosomal stability is no longer sensitive 
to p53 downregulation. 
Figure 7: Downregulation of p53 after tetraploidization does not promote transformation. 
(A) tetraploidy DNA contents are not affected by p53 depletion. 3T3 or 3T3-fusion cells were transfected with either control or p53 
siRNAs (mixture). The cells were transfected again with the same siRNAs at passages 3 and 6. The DNA contents at the indicated passages 
were analyzed with flow cytometry. The positions of the 2N and 4N DNA contents in relation to the parental 3T3 fibroblasts are indicated. 
(b) tetraploid 3t3-fusion cells are not transformed by p53 depletion. Tetraploid 3T3-fusion cells were transfected with either 
control or p53 siRNAs over the first six passages as in panel (A). After passage 8, transformation was assessed with soft agar assays. Mock-
transfected p53-/-3T3-fusion cells were used as positive controls. 
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DIscUssION
Unlike  organisms  such  as  fish  and  amphibian, 
tetraploidization is poorly tolerated in mammals. In fact, 
only a handful of tetraploid human infants have been 
documented [31]. On the cellular level, tetraploids are 
unstable because the extra centrosomes lead to multipolar 
mitosis, segregating the chromosomes unequally among 
the  daughters.  Accordingly,  tetraploid  fibroblasts 
generated by transient blocking of cytokinesis with DCB 
were chromosomally unstable (Figure 1B). In fact, over 
80%  of  mitoses  after  DCB  treatments  were  multipolar 
(data not shown). Tetraploids generated by other methods, 
such as CDK1 inhibitor-promoted mitotic slippage, were 
similarly unstable (our unpublished data). 
Whether tetraploidy per se leads to chromosome 
instability has yet to be established. In this study, we 
studied tetraploidization by cell fusion of spontaneously 
immortalized  mouse  fibroblasts.  Although  many  3T3 
lines are known to contain mutated p53, the Swiss 3T3 
cells used here retain functional p53 [32]. This was also 
confirmed by the activation of both p53 and p21CIP1/WAF1 
after genotoxic stress (Figure 6A). 
Based on the results obtained here, we propose a 
model for p53 in tetraploidization and transformation 
(Figure 8). Due to the increase in centrosomes after cell 
fusion, a large population of cells may undergo mutipolar 
mitosis.  The  unequal  segregation  of  chromosomes 
disrupts gene dosage and homeostatsis, possibly leading 
to the activation of p53-dependent pathways. In agreement 
with this, p53 was strongly induced during the passages 
immediately  after  DCB  treatment  (Figure  1C).  The 
increase in the duration of mitosis after tetraploidization 
may also be responsible for inducing p53 [33]. The 
activation of p53 pathways then eliminated the cells 
by either cell cycle arrest or apoptosis [13]. Only the 
rare cells that were able to undergo bipolar mitosis are 
chromosomally stable as tetraploids and did not activate 
p53 (Figure 8). Flow cytometry analysis (Figure 3A) 
and direct chromosome counting (Figure 3B) indicated 
that the 3T3-fusion cell lines were roughly tetraploidy in 
relation to the parental 3T3 cells. 
How the small number of tetraploid cells could avoid 
multipolar mitosis is unclear. Many cancer cells also appear 
to have mechanisms that suppress multipolar mitosis, 
including functional silencing of extra centrosomes or 
centrosome clustering [26-28]. In a whole genome-wide 
RNAi screen with the near-tetraploid Drosophila S2 
cells, Kwon et al. (2008) identified a variety of genes that 
are required for centrosome clustering, including those 
function in organizing the spindle microtubules and the 
spindle-assembly checkpoint [28]. It was also found that 
the interphase cell shape and adhesion pattern influence 
the success of the subsequent mitosis in cells with extra 
centrosomes. 
From our model, tetraploids should be 
chromosomally stable once they are established. In 
agreement with this, both the chromosome number and 
the nontransformed phenotype of tetraploid 3T3-fusion 
were remarkably stable in culture. No discernable change 
in the ploidy was detected up to passage 34 after clonal 
isolation (Figure 5B). Moreover, the tetraploid 3T3-fusion 
cells retained a doubling time similar to the parental cells 
(Figures 4C and 5C) and were not transformed even after 
Figure 8: the involvement of p53 in chromosomal instability after tetraploidization. Most cells undergo mutipolar mitosis after 
cell fusion. The unequal segregation of chromosomes leads to the activation of p53-dependent pathway, eliminating the cells by either cell 
cycle arrest or apoptosis. Cells that are able to undergo bipolar mitosis are chromosomally stable as tetraploids (upper part of the schematic 
diagram). Subsequent downregulation of p53 in these tetraploids would not affect genome stability. On the other hand, cells that lack p53 
during tetraploidization may survive after undergoing multipolar mitosis (lower part of the schematic diagram). Fast growing sub-tetraploids 
may then be generated.
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extensive culturing (Figure 5A). 
Another characteristic of the model is that the 
subsequent  downregulation  of  p53  in  these  tetraploids 
should not affect genome stability. Accordingly, depletion 
of p53 after tetraploids had been established did not result 
in transformation (Figure 7). In contrast, eliminating the 
p53 responses before tetraploidization by either using 
siRNAs or a p53-/- background promoted chromosomal 
instability and transformation. 
According to our model (Figure 8), cells that lack 
p53 during tetraploidization may survive after undergoing 
multipolar mitosis. Fast growing sub-tetraploids would 
then be generated and took over the population. Consistent 
with this idea, transformed p53-/-3T3-fusion fibroblasts 
exhibited a faster doubling time than the parental cells 
(Figure 4C). There is already compelling evidence that p53 
is involved in guarding against transformation following 
tetraploidization. Fujiwara et al. (2005) indicates that 
tetraploid p53-null mouse mammary epithelial cells 
generated by transient blocking of cytokinesis are prone 
to aneuploidy and tumorigenesis [10]. We also found 
that  induction  of  tetraploidization  of  3T3  fibroblasts 
with DCB in the presence of p53 siRNA could stimulate 
transformation  (Figure  1D).  Likewise,  fusion  of  p53-
/-3T3 cells promoted anchorage-independent growth 
(Figure 5A). 
In conclusion, we found that tetraploidy in fibroblasts 
per se is not intrinsically unstable. Cells at early stages 
of tetraploidization are chromosomally unstable and are 
probably removed by p53-dependent mechanisms. They 
are thus prone to transformation in the absence of p53. In 
contrast, established tetraploids are chromosomally stable 
and resistant to transformation by depletion of p53.
MEtHODs
Materials
All reagents were obtained from Sigma-Aldrich (St. 
Louis, MO, USA) unless stated otherwise. 
cell culture
Swiss 3T3 cells were obtained from the American 
Type Culture Collection (Manassas, VA, USA). To obtain 
p53-/- MEFs, pairs of p53+/- mice of C57BL/6 genetic 
background (JAX Research Systems, Bar Harbor, ME, 
USA) were mated. Timed pregnant females at 15-16 
days  of  gestation  were  sacrificed  followed  by  uterine 
dissection to isolate individual embryos. Embryos were 
washed thoroughly with PBS, followed by removal of 
the head and liver. The embryo body was suspended in 
2 ml of 0.25% trypsin, and then forced through a 1-cc 
syringe with an 18-gauge needle. The tissue homogenate 
was incubated at 37°C for 30 min, triturated by drawing 
the suspension through a pipette, and then divided into 
two 100-mm tissue culture dishes. Cells were grown in 
DMEM  medium  supplemented  with  10%  fetal  bovine 
serum (Invitrogen, Carlsbad, CA, USA). A 3T3 subculture 
schedule was employed by plating 1x106 cells onto 
each of three 100-mm dishes. Every three days the cells 
were trypsinized, pooled, and counted to determine the 
population doublings. The cells were then plated onto three 
new dishes as before. Unless stated otherwise, cells were 
treated with the following reagents at the indicated final 
concentration: Adriamycin (0.2 µg/ml), blasticidin (5 µg/
ml), dihydrocytochalasin B (10 µM), G418 (500 µg/ml), 
hydroxyurea (1.5 mM), nocodazole (0.1 µg/ml). Ionizing 
radiation was delivered with a caesium137 source from an 
MDS Nordion Gammacell 1000 Elite Irradiator (Ottawa, 
Ontario, Canada).
cell fusion and stable cell lines
Cells  were  serum-starved  (cultured  in  DMEM 
supplemented with 0.1% serum) for 24 h, trypsinized, 
collected by centrifugation, and resuspended in 5 ml of 
50 µM SDS in PBS. After incubation at room temperature 
for 5 min, the cells were collected by centrifugation 
and resuspended slowly (over one minute) in 1 ml of 
polyethylenglycol (PEG) 4000 and incubated for another 
minute. The cells were then mixed with 9 ml of serum-free 
medium, collected by centrifugation, washed with serum-
free medium, before resuspension in complete medium. 
Selection medium was added at the second passage after 
fusion. For G418- and blasticidin-resistant cell lines, cells 
were transfected with plasmids expressing the respective 
antibiotic resistant genes. Single colonies were isolated 
after about two weeks of selection. Antibiotics were 
not included in the medium once the cell lines were 
established. 
transfection and sirNAs
Stealth siRNAs targeting mouse cyclin B1, p53, and 
control siRNA were obtained from Invitrogen (Carlsbad, 
CA,  USA).  Transfection  of  siRNA  and  plasmids  was 
carried  out  using  Lipofectamine™  RNAiMAX  and 
Lipofectamine™ 2000 (Invitrogen), respectively. 
Anchorage-independent growth and 
tumorigenicity assays
Approximately 105 cells were seeded in 3 ml of 
0.35% low melting point agarose in growth media. The 
cell suspension was casted onto 60-mm plates with 3 
ml of 0.5% agarose in growth media as an underlay. 
Photographs were taken 14 days after plating. The Oncotarget 2010; 1:  583 - 595 594 www.impactjournals.com/oncotarget
experimental protocol for tumorigenicity was evaluated 
and approved by the Animal Care Committee at HKUST. 
Six to eight week old nude mice (Balb/cnu) were 
maintained in pathogen-free conditions. Cells (2x106) in 
100 µl of PBS were injected subcutaneously into an area 
overlying the hind flank. Mice were regularly checked for 
tumor formation and sacrificed when tumors reached 10-
12 mm in diameter, or after 16 weeks of monitoring. 
Mitotic spread
Cells were treated with 0.1 µg/ml of nocodazole for 
2 h. Following trypsinization, the cells were resuspended 
in 3 ml of 75 mM KCl at 37°C for 20 min, then fixed 
with 3 ml of Carnoy’s fixative (3:1 methanol:glacial acetic 
acid). After incubation at room temperature for 30 min, 
the cells were collected by centrifugation and resuspended 
in fixative. The cell suspension was dropped onto glass 
slides, air dried, and stained with Giemsa stain for 15 min 
before imaging. 
cell imaging
Live cells imaging was performed using a TE2000E-
PFS  inverted  fluorescent  microscope  (Nikon,  Tokyo, 
Japan) equipped with a SPOT BOOST™ EMCCD camera 
(Diagnostic Instrument, Sterling Heights, MI, USA) and 
a  INU-NI-F1  temperature,  humidity  and  CO2 control 
system  (Tokai  Hit,  Shizuoka,  Japan).  Data  acquisition 
and analysis were carried out using the Metamorph 7.5 
software (Molecular Devices, Downingtown, PA, USA). 
Indirect immuno-fluorescent microscopy was performed 
as  described  previously  [34].  FITC-  and  TRITC-
conjugated secondary antibodies were obtained from 
DAKO (Glostrup, Denmark). 
BrdU labeling and flow cytometry
BrdU incorporation, propidium iodide staining, and 
flow  cytometry  analysis  were  performed  as  described 
previously [35].
Antibodies and immunological methods
Immunoblotting was performed as previously 
described  [36].  Monoclonal  antibody  against  β-actin 
was obtained from sources as described previously 
[37]. Monoclonal antibodies against cyclin B1 (sc-245), 
γ-tubulin  (sc-17787),  polyclonal  antibodies  against 
p21CIP1/WAF1 (sc-397) and p53 (sc-6243) were obtained 
from Santa Cruz Biotechnology (Santa Cruz, CA, USA). 
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